Amalgamated Financial’s Pulse Biosciences PLSE Stock Holding History

Amalgamated Financial’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$11K	Buy	+2,273	New	+$18.6K	﹤0.01%	2880

Other funds holding PLSE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Amalgamated Financial's PLSE Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Pulse Biosciences (PLSE) in Q1 2022: 2,273 shares worth $11K. The stake represents ﹤0.01% of the portfolio and ranks #2880 among its holdings.

55 funds tracked by Wall St. Rank hold PLSE as of Q1 2022.

Amalgamated Financial held 2,273 shares of Pulse Biosciences worth $11K as of Q1 2022.
Pulse Biosciences was a new Amalgamated Financial position in Q1 2022.
Pulse Biosciences made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2880 holding.
55 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.